The trademark application Arelaptin was filed by Pharmaselect International Beteiligungs GmbH, a corporation established under the laws of the Republic of Austria (the "Applicant"). The application was published for oppositions on February 8, 2022, and it was registered by office on May 18, 2022 without any oppositions.
The application was filed in German (English was selected as the second language).